Search

everythinglearnresearchcommunity

for

Search:↓

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

A new compound was effective for imaging prostate cancer in rats.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Higher PSA levels are linked to more hirsutism in women with PCOS.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Early balding at 40 increases prostate cancer risk.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Higher DHT in male baldness may protect against prostate cancer.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Higher cholesterol levels increase aggressive prostate cancer risk.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.